Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
27.25
+0.18 (0.66%)
At close: Aug 6, 2026, 4:00 PM EDT
27.36
+0.11 (0.40%)
Pre-market: Aug 7, 2026, 4:18 AM EDT
Beam Therapeutics Employees
Beam Therapeutics had 522 employees as of March 31, 2026. The number of employees increased by 11 or 2.15% since the number was last reported on December 31, 2025.
Employees
522
Change
11
Growth
2.15%
Revenue / Employee
$298,918
Profits / Employee
-$165,747
Market Cap
2.72B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 522 | 11 | 2.15% |
| Dec 31, 2025 | 511 | 28 | 5.80% |
| Dec 31, 2024 | 483 | 47 | 10.78% |
| Dec 31, 2023 | 436 | -71 | -14.00% |
| Dec 31, 2022 | 507 | 166 | 48.68% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Vericel | 398 |
| Tarsus Pharmaceuticals | 370 |
| Vera Therapeutics | 339 |
| Nurix Therapeutics | 317 |
| Immunome | 206 |
| Precigen | 160 |
| Kodiak Sciences | 130 |
BEAM News
- 18 hours ago - Beam Therapeutics price target lowered to $43 from $47 at BofA - TheFly
- 1 day ago - Beam Therapeutics price target raised to $78 from $75 at Canaccord - TheFly
- 2 days ago - Beam Therapeutics reports Q2 EPS ($1.18), consensus ($1.13) - TheFly
- 2 days ago - Beam Therapeutics Reports Second Quarter 2026 Financial Results and Announces First Patient Dosed in Global Pivotal Cohort of BEAM-302 Trial in Alpha-1 Antitrypsin Deficiency (AATD) - GlobeNewsWire
- 2 days ago - Beam Therapeutics Earnings release: Q2 2026 - Filings
- 2 days ago - Beam Therapeutics Quarterly report: Q2 2026 - Filings
- 14 days ago - Beam Therapeutics to Present Updated Data from Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) in Late-Breaking Oral Presentation at the European Respiratory Society (ERS) Congress 2026 - GlobeNewsWire
- 4 weeks ago - Beam Therapeutics Slides: Conference presentation - Filings